Paul Dillon
Impact in
- Toxicology top 0.1%
- Forensic Toxicology and Drug Analysis
- Family Practice top 2%
Papers in
- Pharmacology 11
- Cannabis and Cannabinoid Research 8
- Toxicology 11
- Forensic Toxicology and Drug Analysis 11
- Co-authors
- Jan Copeland (20 shared papers)Peter Gates (7 shared papers)Louisa Degenhardt (7 shared papers)Mark A Bellis (2 shared papers)Karen Hughes (2 shared papers)Wendy Swift (3 shared papers)Julie Hando (2 shared papers)Libby Topp (2 shared papers)
- Journals
- Drug and Alcohol Dependence (4 papers)Addiction (4 papers)Drug and Alcohol Review (3 papers)International Journal of Drug Policy (3 papers)BMC Public Health (2 papers)
- Partner nations
- AustraliaIrelandUnited States
In The Last Decade
Paul Dillon
68 papers receiving 3.2k citations
Paul Dillon's Hit Papers
Peers
Comparison fields: 5 of 164
- Toxicology 615
- Family Practice 71
- Pharmacology 644
- Hepatology 259
- Epidemiology 962
Countries citing papers authored by Paul Dillon
This map shows the geographic impact of Paul Dillon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Dillon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Dillon more than expected).
Fields of papers citing papers by Paul Dillon
This network shows the impact of papers produced by Paul Dillon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Dillon. The network helps show where Paul Dillon may publish in the future.
Co-authors
The 25 scholars most cited alongside Paul Dillon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 71 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Efficacy and Safety of the Farnesoid X Receptor Agonist Obeticholic Acid in Patients With Type 2 Diabetes and Nonalcoholic Fatty Liver Disease Hit paper breakdown → | 2013 | 771 |
| 2 | 2007 | 437 | |
| 3 | 1999 | 281 | |
| 4 | 2003 | 172 | |
| 5 | 2008 | 157 | |
| 6 | 2002 | 113 | |
| 7 | 2005 | 95 | |
| 8 | 2009 | 88 | |
| 9 | 2010 | 86 | |
| 10 | 2005 | 80 | |
| 11 | 2000 | 80 | |
| 12 | 2022 | 78 | |
| 13 | 2003 | 70 | |
| 14 | 2008 | 68 | |
| 15 | 2007 | 56 | |
| 16 | 2020 | 54 | |
| 17 | 2005 | 49 | |
| 18 | 2006 | 47 | |
| 19 | 2017 | 41 | |
| 20 | 2005 | 34 |
About Paul Dillon
Paul Dillon is a scholar working on Pharmacology, Toxicology, Epidemiology, Family Practice and Clinical Psychology, having authored 71 papers that have together received 3.4k indexed citations. Recurring topics across this work include Forensic Toxicology and Drug Analysis (11 papers), Substance Abuse Treatment and Outcomes (9 papers), Cannabis and Cannabinoid Research (8 papers), Medication Adherence and Compliance (7 papers), Hormonal and reproductive studies (6 papers), Psychedelics and Drug Studies (5 papers), Multiple Sclerosis Research Studies (5 papers) and Muscle metabolism and nutrition (3 papers). The work is most often cited by research in Toxicology (615 citations), Family Practice (71 citations), Pharmacology (644 citations), Hepatology (259 citations) and Epidemiology (962 citations). Paul Dillon has collaborated with scholars based in Australia, Ireland and United States. Frequent co-authors include Jan Copeland, Peter Gates, Louisa Degenhardt, Mark A Bellis, Karen Hughes, Wendy Swift, Julie Hando, Libby Topp, Paul Clopton and Mark Kipnes. Their work appears in journals such as Drug and Alcohol Dependence, Addiction, Drug and Alcohol Review, International Journal of Drug Policy and BMC Public Health.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.